Drug-induced localized lipodystrophy

Drug-induced localized lipodystrophy is a rare, acquired, localized lipodystrophy characterized by the appearance of asymptomatic, well-demarcated, variably sized, depressed, lipoatrophic lesions secondary to subcutaneous, intradermic or intramuscular drug injection, including corticosteroids, insulin, human growth hormone and antibiotics. Skin coloration may vary from white or hypopigmented to reddish, pinkish or violaceous. Epidermal atrophy may be also present.

Also known as: lipoatrophy caused by injected drug

5 clinical trials for this condition and its sub-types, 2 tagged with Drug-induced localized lipodystrophy itself.